InforSense and febit Announce OEM for Geniom Platform
News Jun 08, 2009
InforSense Ltd. has announced that febit has integrated key components of the InforSense platform to provide the data analysis and visualization functionality in febit’s new Geniom flexible microarray platform. febit has embedded the InforSense platform, workflows and visualizations and delivers them to customers with each Geniom instrument.
The InforSense platform provides rich data analytics and rapid application development capabilities. InforSense’s VisualSense offers sophisticated, interactive web based visualization of scientific data. The Geniom platform from febit delivers a completely configurable microarray environment as well as a growing portfolio of catalogue biochips.
Key applications include targeted sequence capture prior to Next Generation Sequencing (NGS), as well as classical transcriptomic applications. When used together InforSense and febit enable a wide range of pharmaceutical and medical research customers to more effectively analyze and view their data to improve disease understanding.
“Geniom’s microarrays are completely configurable if needed, requiring very flexible tools for quality control tests, experimental design, data analysis, and visualization,” said Anthony Caruso, VP of Global Informatics at febit.http://www.febit.com
Researchers Awarded $28M for Illuminating Druggable Genome NIH GrantsNews
Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.READ MORE
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug DiscoveryNews
Investment to fund expansion of operations and progression of drug target pipeline.READ MORE
No Country for Old GenesNews
Our modern world is radically different from the one we evolved in, and that creates a mismatch between the environment our genes were evolved to face, and the world those genes now encounter. A new review looks at how certain genes that benefited humans in our genetic past now predispose us to disease in old age.READ MORE
Comments | 0 ADD COMMENT
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018